# A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

> **NCT01010503** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 32 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** tocilizumab [RoActemra/Actemra]

## Key facts

- **NCT ID:** NCT01010503
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010503, "A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01010503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*